• Health-Related Quality of Life, Work Productivity, and Daily Activity Among A Sample of Commercially Insured Patients With Irritable Bowel Syndrome With Constipation or Chronic Constipation In The United States

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Certolizumab Pegol In The Treatment of Axial Spondyloarthritis In Greece

    Nov 1, 2015, 00:00

  • Costo Efectividad Y Costo Utilidad Del Uso De Undecanoato De Testosterona Inyectable En Pacientes Con Hipogonadismo Y Diabetes Mellitus Tipo 2 En Colombia

    Nov 1, 2015, 00:00

  • Oncologist Support for American Society of Clinical Oncology (Asco) Consolidated Payments for Cancer Care Management in the United States (Us)

    Nov 1, 2015, 00:00

  • Proceso De Incorporación De Fármacos A La Lista Positiva De Medicamentos (Lpm) Para Los Prestadores Integrales De Salud- Experiencia En El Ministerio De Salud Pública (Msp) De Uruguay

    Nov 1, 2015, 00:00

  • Prevalence of Transthyretin Familial Amyloid Polyneuropathy In Portugal

    Nov 1, 2015, 00:00

  • Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Health Care Resource Utilization In Asthma

    Nov 1, 2015, 00:00

  • Evaluation of The Cost Effectiveness of Rifaximin-Á In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Belgium

    Nov 1, 2015, 00:00

  • Evaluación de Costo Efectividad de Dolutegravir (dtg) Vs Raltegravir (Ral) En Segunda Línea de Tratamiento en Pacientes Con Vih en Colombia

    Nov 1, 2015, 00:00

  • Cost Of Smoking In Asia

    Nov 1, 2015, 00:00

  • Budget Impact Analysis or Pharmacological Therapy of Chronic Myeloid Leukemia (Cml) with Nilotinib as the Second-Line Treatment in Russian Federation

    Nov 1, 2015, 00:00

  • Effect of Parallel Review Processes for the Marketing Authorization and Reimbursement to Patients and Budget

    Nov 1, 2015, 00:00

  • Mortality Trends in Cardiovascular Disease- a New Model to Visualise the Contribution of Specific Diseases, Cohort Effects and Coding Changes to Overall Mortality Improvement

    Nov 1, 2015, 00:00

  • Prevalence And Burden Cost Of Adverse Drug Reactions (Adrs) In The Faculty Of Medicine Vajira Hospital Navaminthradhiraj University - A Research Implemented To Policy Recommendations

    Nov 1, 2015, 00:00

  • The Cost of Molecular Diagnostic Testing in Oncology – a Workflow Analysis

    Nov 1, 2015, 00:00

  • Incidence and Prevalence Estimations Based on Claims Data – New Methodological Considerations

    Nov 1, 2015, 00:00

  • Real World Evidence in Oncology – Status Quo in Germany

    Nov 1, 2015, 00:00

  • Mortality Trends In Cancers- A New Model To Visualise The Contribution Of Specific Diseases, Cohorts And Coding Changes To Overall Mortality Improvement

    Nov 1, 2015, 00:00

  • A Novel Method for Calculating Medication Adherence to Poly-Pharmacotherapy by Linking General Practice Prescribing Data and Pharmacy Dispensing Records

    Nov 1, 2015, 00:00

  • Title- Factors Influencing Consumers’ Perceived Risk Of Tobacco Products

    Nov 1, 2015, 00:00

  • New Drugs In Non-Small Cell Lung Cancer- Disparities In Requirements For Post-Launch Real-Word Evidence In Europe

    Nov 1, 2015, 00:00

  • Linguistic Validation of The Emphasis-10 Questionnaire- A Patient-Reported Outcome Instrument For Assessing Qol In Pulmonary Hypertension (Ph)

    Nov 1, 2015, 00:00

  • A Cost-Effectiveness Analysis of Secukinumab 300 Mg Vs Current Therapies for The Treatment of Moderate to Severe Plaque Psoriasis In Italy

    Nov 1, 2015, 00:00

  • A Practical Guide To Adding Patient Heterogeneity Into Phase Iii Trials- Results from Imi Getreal Wp2

    Nov 1, 2015, 00:00

  • Characteristics Associated With Annual Bleeding Frequency Among Hemophilia Patients In The United States

    Nov 1, 2015, 00:00

  • Reviewing The Cost-Effectiveness of Chemotherapy and Targeted Therapy for Metastatic Breast Cancer

    Nov 1, 2015, 00:00

  • Modeling Of Clinical Pathways In The Implantation Of Cardioverter Defibrillators From 2006 To 2013 Using The French Hospital P.M.S.I. Database

    Nov 1, 2015, 00:00

  • “Big Data” In Alzheimer’s Disease Research- An Environmental Scan

    Nov 1, 2015, 00:00

  • The Most Frequent Fears and Beliefs of 226 Patients with Rheumatoid Arthritis or Spondyloarthritis, Using a Novel Questionnaire

    Nov 1, 2015, 00:00

  • Disutilities Associated with Central Nervous System (Cns) Side Effects of Antiretroviral Therapy (Art) in Hiv

    Nov 1, 2015, 00:00

  • Assessing Heterogeneity Across Groups of Clinical Trials Based on Aggregate Data

    Nov 1, 2015, 00:00

  • Equivalence of Paper and Electronic Administration of Patient Reported Outcomes- a Comparison in Psoriatic Arthritis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apremilast In Psoriatic Arthritis In Scotland

    Nov 1, 2015, 00:00

  • General Assessment Of Unlicensed Antineoplastic And Immunomodulating Medicine Usage In Turkey

    Nov 1, 2015, 00:00

  • What Lifecycle Management Lessons Can We Learn From Pd-1 Immuno-Oncology Therapies?

    Nov 1, 2015, 00:00

  • Medical Devices – From Licensing To Coverage- Highlights From Argentina, Brazil, Colombia, And Mexico

    Nov 1, 2015, 00:00

  • Cost-Utility of Hexaminolevulinate Blue Light Cystoscopy (Hal) Assisted Transurethral Resection of The Bladder Tumour (Turb) Compared to Turb With White Light Cystoscopy (Wlc) Alone In Patients With Non-Muscle Invasive Bladder Cancer (Nimbc ...

    Nov 1, 2015, 00:00

  • Impacto Presupuestario De Incorporar Linagliptina Para El Tratamiento De La Diabetes En Argentina

    Nov 1, 2015, 00:00

  • Nuevas Moléculas Registradas En Chile Durante El Año 2014

    Nov 1, 2015, 00:00

  • Implementing the Full Economic Evaluations of Medicines in the HTA Programmes in Catalonia- First Steps and Future Perspectives

    Nov 1, 2015, 00:00

  • Correcting for Switching to Second Line Treatment in the Survival Analysis- An Example of the Use of Inverse Probability of Censoring Weighted Analysis

    Nov 1, 2015, 00:00

  • Quantifying The Efficacy-Effectiveness-Gap Using The Example of Metformin

    Nov 1, 2015, 00:00

  • Market Access Entry Agreements in the Italian Market Between January 2006 and April 2015

    Nov 1, 2015, 00:00

  • Vial Sizes Of Pharmaceuticals For Infusion – The Potential For Cost Reductions And Reduced Wastage By Optimising Fill Volumes

    Nov 1, 2015, 00:00

  • Description of Baseline Characteristics of Patients Provided Cancer Care within a Novel Commercial Health Plan Cancer Care Quality Program in the First Year

    Nov 1, 2015, 00:00

  • Pharmaceutical Products And Vaccines Discussed In Social Media- Which Ones Are Patients Talking About?

    Nov 1, 2015, 00:00

  • Connection Between the way of Parenting and the Behavior of Adolescents in the Light of a Survey in Hungary

    Nov 1, 2015, 00:00

  • Effect Of Intervention By Community Pharmacists On Awareness Of Continuing Treatment Among Patients With Hypertension

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Glybera for The Treatment of Lipoprotein Lipase Deficiency

    Nov 1, 2015, 00:00

  • Gastos En Salud En La Intervencion De Tratamiento Y Control De Pacientes Con Hipertension Arterial Del Programa Presupuestal De Enfermedades No Transmisibles En El Perú-2012-2014

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Potential Campylobacter Control Measures in the Food Chain of Indoor Broiler Chicken in the Eu

    Nov 1, 2015, 00:00

  • Modeling The Impact of Potential Differences In Real-Wolrd Adherence With Extended-Half-Life Vs. Conventional Factor Viii And Ix on Bleeding

    Nov 1, 2015, 00:00

  • Efficacy And Safety of Surgical Treatment Options for Primary Angle Closure Glaucoma- a Meta-Analysis of Randomised Controlled Trials

    Nov 1, 2015, 00:00

  • Economic, Public Health, And Humanistic Impact of a Quadrivalent Human Papillomavirus (Hpv6/11/16/18) Vaccination Program For Females And Males Age 9-11 Years in Mexico

    Nov 1, 2015, 00:00

  • Patient Involvement with Pharmaceutical Industry Drug Development and Research- A Review of the Literature

    Nov 1, 2015, 00:00

  • Inequity in Access to Alzheimer Disease Indicated Treatment Across Different Geographic Areas of Turkey

    Nov 1, 2015, 00:00

  • Access to Biological Therapies and Consumption Trends in Bosnia and Herzegovina

    Nov 1, 2015, 00:00

  • Costo De Enfermedades Mentales Prevalentes En Perú

    Nov 1, 2015, 00:00

  • Risk of New-Onset Diabetes Associated with Concomitant Antidepressant, Inhaled Corticosteroids, and Statin Use Among Medicaid Beneficiaries with COPD

    Nov 1, 2015, 00:00

  • Projected Clinical And Economic Impact Of Grazoprevir (Gzr, Mk-5172)/Elbasvir (Ebr, Mk-8742) For Chronic Hcv Genotype 1 Infection In Chronic Kidney Disease

    Nov 1, 2015, 00:00

  • Development of a Preference-Based Instrument- Compared with Eq-5d

    Nov 1, 2015, 00:00

  • Impact of Weight Loss on Patient-Reported Outcomes In The Scale Obesity and Prediabetes Trial of Liraglutide 3.0 Mg As Adjunct to A Diet and Exercise (DE) Programme

    Nov 1, 2015, 00:00

  • Tracking Drug Utilization Data to Enable Conditional Reimbursement of Medicines or Specific Indications In Romania- Analysis of The Requirement for An Effective Implementation

    Nov 1, 2015, 00:00

  • Can We Improve The Inhalation Techniques In Patient With Copd?. Tiepoc Study

    Nov 1, 2015, 00:00

  • The Burden of Adult Pneumococcal Disease in 50+ Population in Hungary

    Nov 1, 2015, 00:00

  • How Does The Additional Benefit Extent of Orphan Drugs Impact Price Negotiations In The German Outpatient Sector?

    Nov 1, 2015, 00:00

  • Consumo De Benzodiazepinas En La Poblacion Geriatrica Atendida En El Hospital Clinico Regional De Concepcion

    Nov 1, 2015, 00:00

  • Direct Cost of Myelodysplastic Syndromes Associated With A Deletion 5q Cytogenetic Abnormality (Del5q Mds) In Patients Who Are Red Blood Cell Transfusion Dependent In Mexico

    Nov 1, 2015, 00:00

  • Evaluación Costo-Efectividad Del Uso Del Régimen Combinado De Mifepristona Y Misoprostol Para Aborto Incompleto O Diferido En Mujeres Con Embarazos De Hasta 12 Semanas De Gestación En Instituciones De Salud Pública En México

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Combined Treatment With Alteplase (Rt-Pa) And Cerebrolysin In Acute Ischemic Hemispheric Stroke In Austria

    Nov 1, 2015, 00:00

  • Inconsistency in the Valuations of Euroqol Eq-5d-5l Health States in China was More Related to Interviewer and to Interview Process than to Respondents’ Characteristics

    Nov 1, 2015, 00:00

  • Evaluación Económica De La Adición De Pertuzumab Al Tratamiento De Trastuzumab+Docetaxel En Pacientes Con Cáncer De Mama Her2 Positivo Metastásico Frente Al Tratamiento Con Trastuzumab+Docetaxel+Placebo, En El Contexto Venezolano

    Nov 1, 2015, 00:00

  • Design And Evaluation of Transdermal Patch of Felodipine

    Nov 1, 2015, 00:00

  • Estudio De Impacto Presupuestal De Daclatasvir Asociado A Asunaprevir Desde La Perspectiva Del Sistema De Salud Publico Chileno

    Nov 1, 2015, 00:00

  • Humanistic and Economic Burden of Focal Drug-Refractory Epilepsy In Europe

    Nov 1, 2015, 00:00

  • The Need to Revise Discount Rates in Belgium, The Netherlands, Poland and the Uk

    Nov 1, 2015, 00:00

  • Heart Failure in a Health Area of Madrid, Spain. Description and Management from Electronic Medical Records

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Herpes Zoster Vaccination In Hong Kong

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Quadrivalent Human Papilloma Virus (Hpv6/11/16/18) Vaccination In Ecuador

    Nov 1, 2015, 00:00

  • Estimation Of Health Benefits Associated To Early Diagnosis And Treatment Of Copd

    Nov 1, 2015, 00:00

  • A Comparison Of Fat Grafting Methods On Operating Room Efficiency And Cost

    Nov 1, 2015, 00:00

  • SERIOUS POST-OPERATIVE INFECTIONS INCREASE RESOURCE UTILIZATION, LENGTH OF STAY, AND INPATIENT MORTALITY IN PEDIATRIC PATIENTS UNDERGOING BRAIN TUMOR RESECTION

    Nov 1, 2015, 00:00

  • Hexaminolevulinate Blue-Light Flexible Cystoscopy In Addition To Standard White-Light Cystoscopy In The Follow-Up Of Non-Muscle Invasive Bladder Cancer- Cost-Consequences During Outpatient Surveillance In Sweden

    Nov 1, 2015, 00:00

  • The Drivers of Facility-Based Immunization Performance and Costs. An Application to Moldova

    Nov 1, 2015, 00:00

  • Chemotherapy Exposure and outcomes Among Patients Diagnosed with Chronic Lymphoid Leukemia

    Nov 1, 2015, 00:00

  • Simeprevir Plus Peginterferon/Ribavirin Cost-Effectiveness Analysis for the treatment of Chronic Genotype 1 Hepatitis C in Colombia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Secukinumab Compared to Ustekinumab In The Treatment of Moderate to Severe Plaque Psoriasis In The Czech Republic

    Nov 1, 2015, 00:00

  • Healthcare Access Differences between Public and Private Insurance Coverage Among Patients with Depression in Brazil

    Nov 1, 2015, 00:00

  • The Cost Effectiveness of Delayed-Release Dimethyl Fumarate Versus Interferon Beta-1b In A Swedish Setting

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Non-Hodgkin’s Lymphoma In Greece

    Nov 1, 2015, 00:00

  • Predictive Analysis of Factors Influencing Health Technology Assessment Recommendation- A Literature Review

    Nov 1, 2015, 00:00

  • Using A Mixed Methods Approach to Develop A Discrete Choice Experiment In Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Cost Per Patient With Sustained Viral Response for Ombitasvir/Paritaprevir/Ritonavir And Dasabuvir With or Without Ribavarin In Genotype 1 Patients With Chronic Hcv In The Netherlands

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Ginkgo Biloba Extract (Egb761® - Tanakan®) for The Treatment of Dementia In The Czech Republic

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Manual Therapy Versus Physical Therapy In Patients With Sub-Acute and Chronic Neck Pain- A Randomized Controlled Trial

    Nov 1, 2015, 00:00

  • Companion Devices- Potential Routes To Market

    Nov 1, 2015, 00:00

  • Comparison of Timed Automata with Discrete Event Simulation for Modeling Personalized Treatment Decisions- the Case of Metastatic Castration Resistant Prostate Cancer

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Apixaban Compared to Low Molecular Weight Heparin/ Edoxaban for Treatment and Prevention of Recurrent Venous Thromboembolism

    Nov 1, 2015, 00:00

  • Doctors’ Failure In Observance Of The Copd Management Guidelines- The Czech Republic 2015 Update

    Nov 1, 2015, 00:00

  • Cyclosporine Is Not The Drug Of Choice For Renal Transplanted Patients And Increases The Risk Of Cardiovascular And Cerebrovascular Accidents

    Nov 1, 2015, 00:00

  • Knowledge And Contraceptive Use Among Currently Married Women Aged 15-49 In Western Kenya

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Sodium Oxybate In Treatment of Cataplexy In Patients With Narcolepy In Turkey

    Nov 1, 2015, 00:00

  • Health Economic Evaluation of Different Vaccination Strategies Against Varicella and Herpes Zoster in Germany

    Nov 1, 2015, 00:00

  • Desarrollo e Implementaci”n de un Modelo de Auditoría Médica Basado en Garantía de Calidad y Supervisi”n Participativa en Ecuador

    Nov 1, 2015, 00:00

  • Apresentação do Programa Desfechos de um Hospital Privado de São Paulo, Brasil

    Nov 1, 2015, 00:00

  • Personalised Breast Screening- Key Drivers Of Cost Effectiveness

    Nov 1, 2015, 00:00

  • Appraising The Cost Of Physician Visits And Technical Procedures In France In The Age Of Open Data

    Nov 1, 2015, 00:00

  • Is Regenerative Medicine Cost-Effective? Evidences From The First Approved Stem Cell Based Product

    Nov 1, 2015, 00:00

  • Efetividade Clínica Comparativa Do Análogo De Insulina Glargina Para Tratamento De Pacientes Acometidos Por Diabetes Mellitus Tipo 1

    Nov 1, 2015, 00:00

  • Analisis de Impacto Presupuestal del uso de Daclatasvir+Asunaprevir en el Tratamiento de Pacientes Con Hepatitis C en Colombia

    Nov 1, 2015, 00:00

  • Early Health Economic Assessment in Innovation Partnerships- Lessons from the European Innovation Partnership on Active and Healthy Ageing

    Nov 1, 2015, 00:00

  • Cost–Utility Analysis of Antihemophilic Factor Rfviii-Fs for Secondary Prophylaxis Vs on-Demand Therapy In Severe Haemophilia A In Italy

    Nov 1, 2015, 00:00

  • The Cancer Drugs Fund and Patient Acces Schemes within the UK- Increased Access to Oncology Medicines or Reduced Value For Money?

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ponatinib Followed By Stem Cell Transplant Versus Best Supportive Care For Uk Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukaemia After Failure of Dasatinib

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Ruxolitinib for The Treatment of Myelofibrosis In Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

    Nov 1, 2015, 00:00

  • Validation of A New Hemophilia-Specific Burden Scale for Caregivers of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)

    Nov 1, 2015, 00:00

  • The Clinical and Economic Burden of Skeletal Related Events in Austria, Czech Republic, Germany, Greece, Italy, Spain and Switzerland- A Comparison Between the use of Denosumab and Zoledronic acid in Patients With Breast Cancer and Bone Met ...

    Nov 1, 2015, 00:00

  • Aflibercept in Combination with Folfiri in Patients with Metastatic Colorectal Cancer- Cost-Effectiveness Based on Velour Best Efficacy Subgroup Post-Hoc Analysis

    Nov 1, 2015, 00:00

  • Regulatory Approval for Oncology Products In Brazil- A Comparison Between The Fda And Anvisa Approval Timelines

    Nov 1, 2015, 00:00

  • Evidence Review Group (ERG) Critique of Systematic Reviews (SR) Submitted to Nice as Part of Single Technology Appraisals (STA) or Multiple Technology Appraisals (MTA) in the Last Three Years

    Nov 1, 2015, 00:00

  • The Budget Impact Of Duoresp® Spiromax® Compared With Commonly Prescribed Dry Powder Inhalers For The Management Of Asthma And Chronic Obstructive Pulmonary Disease In Italy- Estimated Impact Of Inhalation Technique

    Nov 1, 2015, 00:00

  • Cost Impact of The Delay of Broad-Spectrum Antimicrobial Agents De-Esclation on Surgical Wards

    Nov 1, 2015, 00:00

  • Reimbursed Price of Orphan Drugs- A Value Based Framework

    Nov 1, 2015, 00:00

  • Health Status and Quality of Life Among Nurses

    Nov 1, 2015, 00:00

  • Cognitive Testing of A Modified Version of The Faces Pain Scale-Revised In Children With Sickle-Cell Disease

    Nov 1, 2015, 00:00

  • Health Technology Assessment Tools for Technologies Incorporation into Public Health System

    Nov 1, 2015, 00:00

  • Are The Elderly Citizens Ready for Assisted Living Technologies? an Italian Case Study

    Nov 1, 2015, 00:00

  • Multiple Pill Regimens, Single Tablet Regimens and Hiv+ Patients Quality of Life- Evidence from the Straq Study

    Nov 1, 2015, 00:00

  • Assessing Outcomes for Cost-Utility Analyses in Mental Health Interventions- Comparison of Multi-Attribute Utility Instrument Eq-5d with Mental Health Specific Outcomes Ghq12

    Nov 1, 2015, 00:00

  • Analysis of Clinical and Economic Implications of Esmo 2014 Clinical Practice Guidelines for Metastatic Colorectal Cancer Treatment

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Pramipexole Extended Release Monotherapy In Early Parkinson`S Disease

    Nov 1, 2015, 00:00

  • Heterogeneity in Relative Efficacy Assessments (Rea) across European Hta Bodies- Opportunity for Improving Efficiency and Speed of Access to Patients?

    Nov 1, 2015, 00:00

  • Biologic Treatments for Moderate to Severe Naïve Psoriatic Patients- A Budget Impact Analysis In Italy

    Nov 1, 2015, 00:00

  • Use Of Budget Impact Analysis (Bia) In Economic Evaluations Of Drugs And Medical Devices Submitted To The French National Authority For Health (Has)

    Nov 1, 2015, 00:00

  • Anthropometric Study on Mongolians with Metabolic Syndrome

    Nov 1, 2015, 00:00

  • Health Outcomes Evaluation Of New Technologies In Clinical Practi The Case Of The Minimally Invasive Insertable Cardiac Monitor

    Nov 1, 2015, 00:00

  • A Cost Utility Analysis Of Cetuximab For 1st-Line Treatment Of Ras Wild-Type Metastatic Colorectal Cancer- A Summary Of The Submission To All Wales Medicines Strategy Group (Awmsg)

    Nov 1, 2015, 00:00

  • Human Health Damage Modelling in Life Cycle Assessment- A Valuable Addition to the Evaluation of Medical Interventions?

    Nov 1, 2015, 00:00

  • Does A Shorter Protocol Time for Chest Pain Patients Impact Emergency Department Flow? A Queuing Model to Discuss Emergency Department Management Metrics

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Simeprevir and Sofosbuvir Combination Therapy for the Treatment of Genotype 1 Hcv Patients in the Dominican Republic

    Nov 1, 2015, 00:00

  • Social Demographic Characteristics and Direct Medical Costs For Patients With Parkinson’s Disease In Korea - Big Data Analysis From The National Health Insurance Claims Dataset

    Nov 1, 2015, 00:00

  • Direct Costs And Length of Stay In Patients With Methicillin Resistant Versus Methicillin Sensitive Staphylococcus Aureus Infection In A Tertiary Care Hospital In India

    Nov 1, 2015, 00:00

  • Quantifying the Impact of Health-Related Quality of life (Hrql) on Medical Expenditures in Asthma, arthritis, Depression, Diabetes, and Migraine

    Nov 1, 2015, 00:00

  • A hepatite c crônica diminui a qualidade de vida?

    Nov 1, 2015, 00:00

  • Faster Drug Market Access In Italy- is Class C-Nn The Answer?

    Nov 1, 2015, 00:00

  • Costo de Enfermedades Metaxenicas en Los Establecimientos de Salud del Perú

    Nov 1, 2015, 00:00

  • Estimating The Burden Of Diabetes To The French National Health Insurance

    Nov 1, 2015, 00:00

  • A Cost-Utility Analysis of Prolonged-Release Tacrolimus Relative to Immediate-Release Tacrolimus and Ciclosporin In Liver Transplant Recipients In The Uk

    Nov 1, 2015, 00:00

  • Methodological Gaps in the Assessment of the Utility and Burden of Risk Minimisation Interventions

    Nov 1, 2015, 00:00

  • Brexit and Grexit- Implications for The Pharmaceutical Industry

    Nov 1, 2015, 00:00

  • Scoring and Measurement Properties of a Tool to Assess Primary Care Physicians’ Engagement in and Perceived Barriers to Vaccination- the ‘Determinant of Intentions of Vaccination’ (Diva©) Questionnaire

    Nov 1, 2015, 00:00

  • Clinical Effectiveness of Bisphosphonates for Prevention of Fragility Fractures- A Systematic Review and Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Health and Economic Burden of Breast Cancer Mortality in Younger Women Aged 18-44 Years in the United States, 1970-2012

    Nov 1, 2015, 00:00

  • Epidemiologic and Economic Burden Attributable to First Spinal Fusion Surgery- Analysis From An Administrative Database

    Nov 1, 2015, 00:00

  • Assessing The Rationality of Costs of Drug Treatment of Nonalcoholic Steatohepatitis In The Hospital of Ukraine

    Nov 1, 2015, 00:00

  • Costo-Efectividad De La Vacuna Contra El Dengue 2014

    Nov 1, 2015, 00:00

  • Cost-Benefit Analysis Of Yindanxintai Dropping Pills In The Treatment Of Angina Pectoris Caused By Coronary Heart Disease

    Nov 1, 2015, 00:00

  • Validation of The Spanish Version of The Urticaria Activity Score (Uas) and Its Use Over One Week (Uas7)

    Nov 1, 2015, 00:00

  • Evaluacion De Costo-Efectividad De Un Programa De Cuidados Integrales Post-Alta Tipo Hospital De Dia Para Adultos Mayores Comparado Con El Manejo Estandar En El Sistema Publico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Conbercept Versus Ranibizumab For The Treatment of Age-Related Macular Degeneration In China

    Nov 1, 2015, 00:00

  • Cost Effectiveness of Bedaquiline for Patients With Multi-Drug Resistant Tuberculosis in South Korea

    Nov 1, 2015, 00:00

  • The Economic Burden of Pharmaceuticals in People Diagnosed with Depression, Anxiety-Related Disorder and Substance use in Australia

    Nov 1, 2015, 00:00

  • Primary Non-Adherence to Antiosteoporotic Treatment and Associated Factors- A Prospective Cohort Study in Spain

    Nov 1, 2015, 00:00

  • Estimating the additional indirect cost savings of a procalciton-algorithm in adult icu patients with sepsis, as achieved through reduction in antibiotic resistance and c. Difficile infections

    Nov 1, 2015, 00:00

  • Determinants of Women’s Choice of Place of Intrapartum Care In Uganda- An Analysis of Secondary Data From Udhs

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Ingenol Mebutate Versus Diclofenac 3% for Actinic Keratosis Treatment In Spain

    Nov 1, 2015, 00:00

  • The Magnitude of Increased Cardiovascular (Cv) Risk Associated with Familial Hypercholesterolemia (Fh) for use in Economic Analyses

    Nov 1, 2015, 00:00

  • Determinantes Socioeconómicos De La Nutrición Infantil En Colombia

    Nov 1, 2015, 00:00

  • The Use of Single-Arm Evidence In The Comparative Efficacy of Interferon-Free Antivirals for Treatment-Naïve Hepatitis C Genotype 1

    Nov 1, 2015, 00:00

  • Comparison of Two Methods for Estimation of Work Limitation Scores from Health Status Measures

    Nov 1, 2015, 00:00

  • Economic Burden of Controlled Gout, Uncontrolled Gout, and Gout Exacerbated By Common Comorbidities- Results From The 2012-2013 National Health and Wellness Survey

    Nov 1, 2015, 00:00

  • Impact of Negative Symptoms on Quality of Life in Patients with Schizophrenia

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Of Palivizumab In Premature Infants And Children With Chronic Lung Disease In Mexico

    Nov 1, 2015, 00:00

  • Assessing The Burden of Systemic Lupus Erythematosus In Belgium Using A Longitudinal Hospital Database

    Nov 1, 2015, 00:00

  • Blood Glucose Test Result From Employees At Health Clinic of Songino Khairkhan District

    Nov 1, 2015, 00:00

  • Introduction Of Mirabegron In The Czech Republic From Payer’s Perspective – 1 Year Overview

    Nov 1, 2015, 00:00

  • Longitudinal Modeling The Effect Of Lisdexamfetamine Dimesylate And Changes In Binge Eating Frequency On Disability In Patients With Binge Eating Disorder

    Nov 1, 2015, 00:00

  • Estimating the Budget Impact of Switching from Bortezomib Intravenous (Iv) to Bortezomib Subcutaneous (Sq) in the Treatment of Relapsed/Refractory Multiple Myeloma (Mm) in Mexico

    Nov 1, 2015, 00:00

  • Indirect Comparisons in Benefit Assessment

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis of Intravitreal Aflibercept Compared with Ranibizumab on-Label In Patients with wet Age-Related Macular Degeneration (Wamd)

    Nov 1, 2015, 00:00

  • The Willingness Of Cancer Outpatients To Complete Patient-Reported Outcome Measures Outside Of The Clinic

    Nov 1, 2015, 00:00

  • Patient use of Eclinical Technology to Research, Track, And Self-Manage Chronic Disease

    Nov 1, 2015, 00:00

  • Statins Use And The Risk Of Hematological And Non-Hematological Malignancies- A Meta-Analysis Of 53 Observational Studies

    Nov 1, 2015, 00:00

  • Potential Societal Value of Biosimilars Adoption- The Example of UK

    Nov 1, 2015, 00:00

  • Proposal for A Regulatory Framework for Health Apps to Ensure A Patient Centered Competition Between Providers

    Nov 1, 2015, 00:00

  • Patient Characteristics and Disease Burden of Osteoporosis In Post Menopausal Women At Increased Risk of Fracture In Germany

    Nov 1, 2015, 00:00

  • Eight Ways to Improve The Interpretation and Reporting of Cost-Effectiveness Analyses of Screening Interventions

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Apremilast on Moderate to Severe Psoriasis In Spain

    Nov 1, 2015, 00:00

  • A Comparison Of Key Components Of The Hta Core Model And The Amcp Format

    Nov 1, 2015, 00:00

  • Assessment Of Pharmacist-Led Home-Based Educational Intervention Among Type 2 Diabetes Patients In The State of Penang, Malaysia

    Nov 1, 2015, 00:00

  • Exploring Before And After Risk-Sharing Scheme Implementation During 8.5 Years Focused On Anticancer Drugs

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Drugs- Systematic Review

    Nov 1, 2015, 00:00

  • Factors Associated with Inadequate Pain Relief in Patients with Primary Knee Osteoarthritis in Portugal- An Analysis from the Survey of Osteoarthritis Real World Therapies (Sort)

    Nov 1, 2015, 00:00

  • Cost-Minimization Analysis (CMA) of Canagliflozin Compared to Glimepiride and Sitagliptin as Dual Therapy in Combination with Metformin

    Nov 1, 2015, 00:00

  • Resource Use And Health Care Costs Of Copd Patients At The End Of Life- A Systematic Review

    Nov 1, 2015, 00:00

  • Association Among Calendar Packaging And Medication Adherence- Findings From A Focus Group Discussion Among Hypertensive Patients In Penang, Malaysia

    Nov 1, 2015, 00:00

  • Managing Patients With Statin-Associated Symptoms- Does Real-World Clinical Practice Align With Clinical Guidelines And Hta Recommendations In Europe?

    Nov 1, 2015, 00:00

  • The Association Between Smoking Cessation Outpatient Visits And Total Medical Costs- An Analysis Of Japanese Employee Based Public Health Insurance Data

    Nov 1, 2015, 00:00

  • Burden of Disease in Patients with Glaucoma in Brazil-

    Nov 1, 2015, 00:00

  • Economic Costs of Bacterial Meningitis- A Systematic Review

    Nov 1, 2015, 00:00

  • Inequalities In Access to Treatment for Multiple Sclerosis In England Continue Despite Service Improvement Initiatives And Policy Reforms

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of A Left Atrial Appendage Closure Device In Patients With Non-Valvular Atrial Fibrillation Unable or Unwilling to Tolerate Oral Anticoagulant Therapy In Italy And Spain

    Nov 1, 2015, 00:00

  • Review of Patient Reported Outcome Measures used in Clinical and Cost-Effectiveness Studies to Measure Utilities in the Treatment of Psoriatic Arthritis and Ankylosing Spondylitis

    Nov 1, 2015, 00:00

  • Prices Changes for Patent-Protected Innovative Drugs in the Top 5 Eu Pharmaceutical Markets

    Nov 1, 2015, 00:00

  • Comparison of Chronic Hepatitis C Treatment Efficacy in Randomized Controlled Trials and Real-Life Studies - Influence of Study Design in the Sustained Virological Response- A Systematic Review of Published Literature

    Nov 1, 2015, 00:00

  • Patient Understanding and Attitudes About Biosimilars- An International Cross-Sectional Survey

    Nov 1, 2015, 00:00

  • Impact Of Cancer Diagnosis And Treatment On Glycaemic Control Among Individuals With Colorectal Cancer Using Glucose Lowering Drugs

    Nov 1, 2015, 00:00

  • Delays in Diagnosis of Breast Cancer in Gree Findings from a Qualitative Study

    Nov 1, 2015, 00:00

  • Extracting And Using Data From Electronic Medical Records (Emr) To Monitor Quality Of Care And Prescription Patterns For Diabetes Prevention And Control In Outpatient Clinics Of Low And Mid Resources Countries- The Case Of Colima, Mexico

    Nov 1, 2015, 00:00

  • Análisis de Costo-Efectividad de Anidulafungina en el Tratamiento de la Candidiasis Invasiva en Colombia

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Various Treatment Strategies For Patients With Chronic Venous Insufficiency Of The Lower Limbs

    Nov 1, 2015, 00:00

  • Relapsing Remitting Multiple Sclerosis Patients Initiated on Oral Dmf Report A Better Quality of Life Compared to Patients on Platform Therapies As Measured By Eq-5d

    Nov 1, 2015, 00:00

  • Costos de Medicamentos en el Marco de un Programa Presupuestal Para el Vih/Sida en Perú, 2012-2014

    Nov 1, 2015, 00:00

  • Cross-Country Profile of Adult Caregivers

    Nov 1, 2015, 00:00

  • Development of A Conceptual Model of Multiple Myeloma for Use In Economic Modelling- A Systematic Literature Review to Identify The Evidence Base

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of The Use of Voriconazole, Posaconazole And Micafungin In The Primary Prophylaxis of Invasive Fungal Infections In Recipients of Allogeneic Hematopoietic Stem Cell Transplants In Spain

    Nov 1, 2015, 00:00

  • Increasing Precision of Real-World Data Estimates- The Importance of A Step-Wise Process to Limit Data Collection Errors And Data Incompleteness

    Nov 1, 2015, 00:00

  • Diabetes In Turkey- Analysis of Patient Characteristics

    Nov 1, 2015, 00:00

  • The Impact of Consumer-Directed Health Plans on Price Shopping

    Nov 1, 2015, 00:00

  • Survey of Neurologist’s Current Practices in Evaluation of Multiple Sclerosis to Identify Domains for a New Clinician-Reported Measure

    Nov 1, 2015, 00:00

  • Experiences of Italian Patients With Diabetes- An Analysis of The Eu Roper Diabetes Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Cardioprotective Effect of Dexrazoxane (Cardioxane®) in Advanced/Metastatic Breast Cancer Patients Treated with Anthracycline-Based Chemotherapy in México

    Nov 1, 2015, 00:00

  • The Evolution of HTA as a Coverage Decision-Making Tool in the Middle East and North Africa Region

    Nov 1, 2015, 00:00

  • Measurement Invariance of the Whoqol-Old Module Across Different Demographic Groups in Taiwan’s Elderly People

    Nov 1, 2015, 00:00

  • The Dutch Melanoma Treatment Registry As Blueprint For Using Registry Data To Improve Health Care Decision Making

    Nov 1, 2015, 00:00

  • Assessment of Tofacitinib For Rheumatoid Arthritis From The Perspective of The Brazilian Healthcare System

    Nov 1, 2015, 00:00

  • Assessing Retrospective Data on the Management of Ischemic Stroke

    Nov 1, 2015, 00:00

  • An Economic Analysis of Informal Care Provision in Ireland

    Nov 1, 2015, 00:00

  • Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study

    Nov 1, 2015, 00:00

  • Disease Burden, Outcomes and Costs Among Adults Admitted To Hospital In The United Kingdom (Uk) Due to Plaque Or Erythrodermic Psoriasis

    Nov 1, 2015, 00:00

  • Liraglutide vs Other Daily GLP-1 Analogues in People with Type 2 Diabetes- A Network Meta-Analysis

    Nov 1, 2015, 00:00

  • Use Pattern Narcotic Analgesics For Cancer Patient In South Korea - Claims Data Analysis

    Nov 1, 2015, 00:00

  • Health Utilities Associated with Hypoglycemic Events in Type 2 Diabetes Mellitus (T2DM) Patients Receiving Basal-Bolus Insulin Therapy

    Nov 1, 2015, 00:00

  • Characteristics of Acne Vulgaris In European Adolescents And Patients Perceptions

    Nov 1, 2015, 00:00

  • Cost Of Illness In Aortic Stenosis Patients

    Nov 1, 2015, 00:00

  • Governance, Decision-Making, and Universal Health Coverage- perceptions from Chilean Health Decision-Makers

    Nov 1, 2015, 00:00

  • O Método Paraconsistente Como Suporte Às Tomadas De Decisão Em Saúde

    Nov 1, 2015, 00:00

  • A Cross-Sectional Epidemiological Cancer Registry In Egypt

    Nov 1, 2015, 00:00

  • Evaluation Of A Payment By Results Scheme In A Catalan Cancer Center- Gefinitib In Egfr Mutation-Positive Advanced Non-Small Cell Lung Cancer

    Nov 1, 2015, 00:00

  • Pro Claims in Fibromyalgia- A Review of the Labels of Products Approved by the Fda and the Ema

    Nov 1, 2015, 00:00

  • Grand-4- The German Retrospective Analysis on Persistence in Women with Osteoporosis Treated with Bisphosphonates or Denosumab

    Nov 1, 2015, 00:00

  • Validation of a Short “Occupational Disability Index” As a Measure for Disease Impacts on Work Performance and Occupational Handicaps

    Nov 1, 2015, 00:00

  • Avoiding Overestimation In Annualization of Event Risk from Risk Functions for use in Economic Modeling

    Nov 1, 2015, 00:00

  • Diagnoses And Treatment Patterns For Non-Small Cell Lung Cancer (Nsclc) Within The Private Health System In Brazil

    Nov 1, 2015, 00:00

  • Assessment of Real-World Treatment Patterns and Outcomes In Relapsed or Refractory Multiple Myeloma- Evidence From A Brief Multi-Country Survey of European Physicians

    Nov 1, 2015, 00:00

  • Costo En Salud De La Intervenci”N En La Atenci”N Del Parto Normal En El Peru 2009 Y 2014

    Nov 1, 2015, 00:00

  • Impact of Essential Health Benefit Benchmark Plans on Us Market Access

    Nov 1, 2015, 00:00

  • Eastern Cooperative Oncology Group (Ecog) Performance Status (Ps) Is An Independent Predictor Of Hrqol In Unresectable Or Metastatic Melanoma

    Nov 1, 2015, 00:00

  • Health Care Resource use and Costs Among Polycythemia Vera Patients in the United States- Results from an Observational Cohort Study

    Nov 1, 2015, 00:00

  • Wintertime Surgery Increases The Risk of Osteonecrosis After Internal Fixation of Femoral Neck Fracture

    Nov 1, 2015, 00:00

  • Haemodialysis Versus Non-Dialysis Therapy Among Older Adults With Stage 5 Chronic Kidney Disease- A Comparison of Health-Related Quality of Life

    Nov 1, 2015, 00:00

  • Measuring Generic Health-Related Quality Of Life And Impact Of Health Resource Utilization In Adults With Cystic Fibrosis

    Nov 1, 2015, 00:00

  • Costos de Hospitalización Por Infección Respiratoria Aguda Grave (Irag) en Guatemala

    Nov 1, 2015, 00:00

  • Tailoring Sponsor-Payer Engagement to Facilitate Effective and Fair Patient Access

    Nov 1, 2015, 00:00

  • Development of A Cost-Effectiveness Analysis Framework for Modeling Treatment of Alzheimer’s Disease And Mild Cognitive Impairment

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis of Urothelial Transitional Cell Cancer Treatment with Vinflunine in Patients Resistant to the Platinum-Based Treatment Regimes

    Nov 1, 2015, 00:00

  • Cost-Benefit Analysis of Whole Body Bone Scintilography in the Pre-Trasnplant Assesment of Adult Patients Beares of Hepatocellular Carcinoma in a Liver Tranaplant List in the South of Brazil

    Nov 1, 2015, 00:00

  • Priority issues and Recommendation Selection in Cancer Pain Management

    Nov 1, 2015, 00:00

  • Partitioned Survival Versus State Transition Modeling in Oncology- a Case Study with Nivolumab in Advanced Melanoma

    Nov 1, 2015, 00:00

  • Stochastic Multicriteria Acceptability Analysis In A Bayesian Framework

    Nov 1, 2015, 00:00

  • ANALYSIS OF Hiv – Infection in Kazakhstan

    Nov 1, 2015, 00:00

  • A Systematic Review of The Impact of Improved Housing Interventions on Health In Low And Middle Income Tropical Settings

    Nov 1, 2015, 00:00

  • Nice Medical Technologies Evaluation Programme – Influence Of The Review On Uptake By Procurement Managers And Key Stakeholders

    Nov 1, 2015, 00:00

  • Understanding The Underutilisation Of Evidence From Economic Evaluations In Healthcare- A Mixed Methods Design

    Nov 1, 2015, 00:00

  • Burden of Dyslipidaemia in Patients at High Risk for Cardiovascular (Cv) Events- Results of a Canadian Study

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Sitagliptin Compared to Sulphonylurea as an Add-on to Metformin in the Treatment of Type 2 Diabetes in Greece

    Nov 1, 2015, 00:00

  • Tools for Measuring Workability – Results Derived from Literature and Expert Interviews

    Nov 1, 2015, 00:00

  • The Cost Effectiveness Of Idelalisib In Chronic Lymphocytic Leukaemia In England And Wales

    Nov 1, 2015, 00:00

  • Prevalence and Incidence Estimations in German amnog Applications – The Role of Real-World Evidence (RWE)

    Nov 1, 2015, 00:00

  • Medical Cost Of Patients With Non-Valvular Atrial Fibrillation (Nvaf) And Treated With Vitamin K Antagonists (Vkas) According To Inr Control Status In Spain

    Nov 1, 2015, 00:00

  • Value-Based Pricing Scheme for new Technology in Consideration of Cost-Effectiveness Dominance to the Control

    Nov 1, 2015, 00:00

  • Biologic treatments for moderate-severe psoriasis. What efficacy gives you, cost should not take it away

    Nov 1, 2015, 00:00

  • Quality Of Life And Perspectives Of Happiness In Middle-Aged And Older People With Dysphagia

    Nov 1, 2015, 00:00

  • Estimaci”N de Costos Directos Asociados al Cambio de Terapia iv A oral en Infecci”N Complicada de Piel y Tejidos Blandos en Chile

    Nov 1, 2015, 00:00

  • Adherence to Glatiramer Acetate 40 Mg Versus Oral Disease-Modifying Therapies for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Introduction Of An Organizational Model Of Telemedicine In Management Of Oral Anticoagulant Therapy- A Budget Impact Analysis From Italian Payer Perspective

    Nov 1, 2015, 00:00

  • Pharmacy Information System In Saudi Hospitals- How Far Is It To Meet Pharmacy Benefit Management Program Requierments?

    Nov 1, 2015, 00:00

  • Investigating The Accessibility Of Uninsured Population To Health Services In Greece

    Nov 1, 2015, 00:00

  • Practical Considerations in the Application of Statistical Methods for Treatment Switching

    Nov 1, 2015, 00:00

  • Nationwide Trend Analysis of Targeted Therapies for Treatment Of Malignant Neoplasms of The Eye In Taiwan (2009-2016)

    Nov 1, 2015, 00:00

  • Systematic Literature Review of Health State Utility Values In Patients With Migraine

    Nov 1, 2015, 00:00

  • Increased Risk of Osteoporosis In Depressed Patients- A Real World Data Study Conducted In Italy

    Nov 1, 2015, 00:00

  • Patients’ Priorities For Treatment In Severe Asthma

    Nov 1, 2015, 00:00

  • Comparison of Network Meta-Analysis and Traditional Meta-Analysis for Prevention of Relapses In Multiple Sclerosis

    Nov 1, 2015, 00:00

  • The Evolving Landscape of Early Access Programmes- Comparisons and Implications for Market Access

    Nov 1, 2015, 00:00

  • Evaluation Of Resource Utilizaton For Chemotherapy Induced Nausea And Vomiting (Cinv) In Patients Treated With Anthracycline+Cyclophosphamide (Ac) For Solid Cancers With And Without Nk-1 Based Regimens

    Nov 1, 2015, 00:00

  • Mapping Health State Utility Values From Eortc Data Collected From A Clinical Trial Population With Relapsed/Refractory Multiple Myeloma

    Nov 1, 2015, 00:00

  • Review of Patient Reported Outcomes In Glaucoma

    Nov 1, 2015, 00:00

  • Early Economic Evaluation of Short-Term Variability of Qt Intervals As A Potential Test for Predicting The Effectiveness of Icd Implantation In Patients With Heart Failure

    Nov 1, 2015, 00:00

  • Endovascular Interventions For Treatment Of Femoropopliteal Peripheral Artery Disease- Updated Budget Impact Analysis For Germany Based On Latest Clincal Evidence

    Nov 1, 2015, 00:00

  • Trio H’s (Hyperglycemia, Hypertension, Hyperlipidemia)- Undiagnosed Modifiable Risk Factors In Malaysia Rural Community

    Nov 1, 2015, 00:00

  • Design Of Three New Condition-Specific Questionnaires To Assess Quality Of Life, Symptoms And Treatment Satisfaction Of Patients With Abdominal Aortic Aneurysm- The Aneurysm-Dqol, Aneurysm-Srq And Aneurysm-Tsq

    Nov 1, 2015, 00:00

  • Measuring the Impact of Secondary Progressive Multiple Sclerosis (Spms) in the Ascend Trial- Equating the Msis-29, Msws-12, Abilhand-56 and Sf-36

    Nov 1, 2015, 00:00

  • Health Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine In Finnish Home Care Customers ≥50 Years With Underlying Chronic Medical Conditions

    Nov 1, 2015, 00:00

  • Burden of Metastatic Renal Cell Carcinoma in France From 2008 To 2013- Analysis of the French National Hospital Database

    Nov 1, 2015, 00:00

  • Increased Usage of Calcium Free Balanced Solutions (Bal) in Lieu of 0,9% Saline in Patients Meeting Sirs (Systemic Inflammatory Response Syndrome) Criteria- a Private Brazilian Hospital Perspective

    Nov 1, 2015, 00:00

  • Physical Functioning and Pain in Chronic Low Back Pain- a Systematic Review of Psychometric Properties of Various Outcomes Measures

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Canacinumab In The Treatment of Patients With Muckle–Wells Syndrome In The Russian Federation

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Dulaglutide 1.5mg Once Weekly for the Treatment of Patients with Type Two Diabetes Mellitus in Sweden

    Nov 1, 2015, 00:00

  • Impact of Grexit on Pharmaceutical Pricing- An International Reference Pricing Analysis

    Nov 1, 2015, 00:00

  • A Decision Options Approach to Antibiotic RD Investment

    Nov 1, 2015, 00:00

  • Adjusting For Cross-Over In Oncology Trials- Approaches Taken To Support Drug Reimbursement In Australia

    Nov 1, 2015, 00:00

  • Direct Treatment Costs Of Stroke In Turkey

    Nov 1, 2015, 00:00

  • Evaluación Económica del uso de La Gasa Sintética Frente a la Gasa de Algodón de Pieza Única En El Manejo de Heridas en Colombia

    Nov 1, 2015, 00:00

  • Steering vaccines through the uk system - what factors influence the likelihood of positive and negative recommendations?

    Nov 1, 2015, 00:00

  • A Validity and Reliability Study of the Poverty Related Quality of Life Questionnaire in a Turkish Patient Population

    Nov 1, 2015, 00:00

  • Comparison of Bazedoxifene/Conjugated Oestrogens Vs Current Therapies in the Treatment of Postmenopausal Symptoms- Systematic Review and Meta-Analysis

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of The Fixed Combination Indacaterol/Glycopyrronium Vs. Tiotropium And Salmeterol/ Fluticasone In The Management Of Copd In Greece

    Nov 1, 2015, 00:00

  • Mortality In A University Pediatric Hospital In Colombia 2000 – 2014

    Nov 1, 2015, 00:00

  • The Impact Of New Endovascular Therapies For Femoropopliteal Arterial Disease On Therapy Utilization And Case Volumes In Germany, 2009-2013

    Nov 1, 2015, 00:00

  • Is Edoxaban Cost-Effective For Non-Valvular Atrial Fibrillation Patients Treated With Vitamin K Antagonists In Spain?

    Nov 1, 2015, 00:00

  • Competition And Strategic Regulation In The Argentine Pharmaceutical Market- A Comparative Study Of Six Therapeutic Classes

    Nov 1, 2015, 00:00

  • French Health Technology Assessment Of Antineoplastic Drugs Indicated In The Treatment Of Solid Tumours- Perspective For Future Trends

    Nov 1, 2015, 00:00

  • The Cumulative Analysis of Checklist Questionnaires Filled Out by the Hungarian HTA Office

    Nov 1, 2015, 00:00

  • Network Meta-Analysis of Oral Anticoagulants for Primary Prevention, Treatment and Secondary Prevention of Venous Thromboembolic Disease, and for Prevention of Stroke in Atrial Fibrillation

    Nov 1, 2015, 00:00

  • Modelling Health Benefits Associated to Early Diagnosis and Treatment of Copd

    Nov 1, 2015, 00:00

  • Costo-Efectividad Del Desfibrilador Externo Automático (Dea) Comparado Con Reanimación Cardiopulmonar Básica (Rcp) En Colombia

    Nov 1, 2015, 00:00

  • Using An Economic Model To Choose Initial Appropriate Antibiotic Therapy Based On Differences In In-Vitro Susceptibility To Ceftolozane/Tazobactam And Piperacillin/Tazobactam

    Nov 1, 2015, 00:00

  • Methodology of International Comparison of Pharmaceutical Prices

    Nov 1, 2015, 00:00

  • Analysis of the Reports of the National Committee for Technology Incorporation (Conitec) in the Brazilian Public Health System (Sus), 2012-2015

    Nov 1, 2015, 00:00

  • Biosimilars- Accessing the Uk Market

    Nov 1, 2015, 00:00

  • Effectiveness and Safety of New and Traditional Oral Anticoagulants in a Population-Based Cohort of New Users with Atrial Fibrillation

    Nov 1, 2015, 00:00

  • A Comparison of Time to Launch and Reimbursement for New Medicines across Developed Countries

    Nov 1, 2015, 00:00

  • Understanding Local Commissioning Decisions on New Pharmacotherapies In The Uk

    Nov 1, 2015, 00:00

  • Reference Pricing For Laboratory Tests In The United States- Impact On Prices And Spending

    Nov 1, 2015, 00:00

  • Resource Utilisation And Costs In Patients With Post-Stroke Spasticity In The United Kingdom

    Nov 1, 2015, 00:00

  • Willingness to Pay for Quality-Adjusted Life Years In Patients With Diabete

    Nov 1, 2015, 00:00

  • Costos económicos de la otitis media aguda. Una revisión de la literatura

    Nov 1, 2015, 00:00

  • condition Specific Utilities- Impact on Icer in a Markov Model for Multiple Sclerosis

    Nov 1, 2015, 00:00

  • Using Financial Incentives to Motivate Stair Use In A Workplace Setting- Results From A Randomized Controlled Trial

    Nov 1, 2015, 00:00

  • Patient Profile of New Users of Novel Oral Anticoagulants in non-Valvular Atrial Fibrillation (Nvaf)- Real-World Evidence from Primary Care Data in Germany

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Exenatide Twice Daily (BID) Versus Insulin Glargine Once Daily (QD) as Add-on Therapy in Chinese Patients with Type 2 Diabetes Mellitus Inadequately Controlled by Oral Therapies

    Nov 1, 2015, 00:00

  • Prevalence Of Chronic Kidney Disease In India- A Systematic Review And Meta-Analysis Of Observational Studies

    Nov 1, 2015, 00:00

  • Innovation Ranking in France and Italy- Differences and their Impact on Pricing and Reimbursement Processes

    Nov 1, 2015, 00:00

  • Decision-Analytic Modeling Studies- An Overview for Clinicians Using Dlbcl As An Example

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Guideline for Positive Drug List Application Purposes Implemented In Bulgaria

    Nov 1, 2015, 00:00

  • Insurance Plan Switch Patterns Among Breast Cancer Patients Compared to Non-Cancer Patients

    Nov 1, 2015, 00:00

  • Trends In Self-Rated Health Status Among Adults In Greece (2002-2015)

    Nov 1, 2015, 00:00

  • Outcome of Harkány Thermal Water Completed Puva Therapy Versus Traditional Puva Therapy of Psoriatic Patients

    Nov 1, 2015, 00:00

  • Disease Mapping And Spatial-Temporal Analysis Of Hospital Admissions Due To Heart Failure In Portugal

    Nov 1, 2015, 00:00

  • Cytogenetics And Dopamine Receptor (Drd2) Gene Polymorphism In Schizophrenia Patients

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Zoledronic Acid Versus Alendronic Acid In The Treatment of Osteoporosis In Postmenopausal Egyptian Patients- Decision Analysis

    Nov 1, 2015, 00:00

  • Assessing Japan’s Three Early Access Programs Based On Recent Discussions- Scope And Financial Aid

    Nov 1, 2015, 00:00

  • Cardiovascular Event Rates in a High-Risk General Population Cohort of 340,000 Individuals in the United Kingdom

    Nov 1, 2015, 00:00

  • Long-Term Cost-Effectiveness of Transanal Irrigation In Patients With Neurogenic Bowel Dysfunction Who Have Failed Standard Bowel Care

    Nov 1, 2015, 00:00

  • Patient Diagnostic Therapeutic Pathway For Patients With Psoriasis The Organisational Analysis of 13 Excellence Centres Of The Tuscany Region (Italy)

    Nov 1, 2015, 00:00

  • Análisis de Costo-Efectividad de Inyeccion Intravitrea de Ranibizumab Versus Aflibercept en el Tratamiento de la Perdida Visual Secundaria a Edema Macular Diabetico Desde la Perspectiva del Sistema de Salud en Colombia

    Nov 1, 2015, 00:00

  • A Mixed Treatment Comparison (Mtc) to Compare the Efficacy of Anti-Thrombotic Agents in Treatment and Secondary Prevention of Venous Thromboembolism (Vte) in Patients with Deep Vein Thrombosis (Dvt)

    Nov 1, 2015, 00:00

  • Medical Care And Costs of Patients With Systemic Lupus Erythematosus In Taiwan

    Nov 1, 2015, 00:00

  • Direct Costs And Healthcare Resource Use Associated With Advanced Melanoma In Portugal

    Nov 1, 2015, 00:00

  • Evaluaci”N De La Prescripci”N Medica De Antihipertensivos En Los Médicos Cardi”Logos Del Hospital Nacional Edgardo Rebagliati Martins, Lima (Peru)

    Nov 1, 2015, 00:00

  • Determinantes y Barreras Socioeconómicas del Acceso A Los Servicios de Salud en Las Regiones de Colombia

    Nov 1, 2015, 00:00

  • Effects Of Lifestyle Interventions On Body Mass Index In Breast Cancer Patients

    Nov 1, 2015, 00:00

  • Evaluation of The Cost Effectiveness of Rifaximin-á 550mg In The Reduction of Recurrence of Overt Hepatic Encephalopathy In Sweden

    Nov 1, 2015, 00:00

  • Cost-Utility Analysis of Apremilast for The Treatment of Psoriatic Arthritis In The Italian Setting

    Nov 1, 2015, 00:00

  • The Cost-Effectiveness Of Treatment For Chronic Heart Failure- A Systematic Review

    Nov 1, 2015, 00:00

  • Survival And Cost Among Photodynamic Therapy Patients With Non-Small Cell Lung Cancer

    Nov 1, 2015, 00:00

  • Pharmacoeconomic Analysis Of Anidulafungin, Micafungin, Caspofungin And Fluconazole In The Treatment Of Candidemia And/Or Invasive Candidiasis In Non-Neutropenic Adult Patients In Spain

    Nov 1, 2015, 00:00

  • Dispensing of The Combination of Amoxicillin With Clavulanic Acid to Elderly Patients- A Database Analysis

    Nov 1, 2015, 00:00

  • Preferences for Using Phone Calls, Text Messaging, and Email to Communicate with Physicians Among Patients with four chronic diseases

    Nov 1, 2015, 00:00

  • New Copd Medicinal Products Entrance Analysis And Their Influence On The Number And Cost Of Hospitalizatons Due To Copd Exacerbations

    Nov 1, 2015, 00:00

  • Qualitative and Quantitative Analysis of The Scottish Medicines Consortium (Smc) Advice

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Secukinumab Compared to Ustekinumab In Patients With Psoriasis From A Swedish Health Care Perspective

    Nov 1, 2015, 00:00

  • Mobile Phone Use And Willingness To Pay For Sms For Diabetes In Bangladesh

    Nov 1, 2015, 00:00

  • Medication Adherance and Satisfaction With Treatment In Patients With Diabetes Mellitus Receiving Oral Combination Therapy- Data of A Real-World Study

    Nov 1, 2015, 00:00

  • Study on Quality of Nursing Care and Assessment of Safety

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Opioid Substitution Treatment in Slovenia

    Nov 1, 2015, 00:00

  • Cost Effectiveness Analysis of The Use of Daclatasvir for the Treatment of Hepatitis C Virus (Hcv) Genotypes 3 in Cirrhotic Patients Within the Italian National Health Service

    Nov 1, 2015, 00:00

  • Cost-Effectiveness of Rapid-Acting Analog Insulin for Type 1 Diabetes In The Uk Setting

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis Of Pertuzumab For Metastatic Her2-Positive Breast Cancer In Japan

    Nov 1, 2015, 00:00

  • Budget Impact of Perampanel for The Treatment of Patients With Partial-Onset Seizures (Pos) In Russia

    Nov 1, 2015, 00:00

  • Budget Impact Analysis of Cerebrolysin In The Treatment of Acute Ischemic Stroke of Moderate and Severe Degrees of Severity In The Russian Federation

    Nov 1, 2015, 00:00

  • The Research on The Relationship Between The Ovarian Function Damage With Fluorosis and The Protective Effect of Selenium

    Nov 1, 2015, 00:00

  • The Impact of Societal Views on Market Access- Case Studies For Utilization of Hpv Vaccines in Cervical Cancer and Prep Hiv Preventive Therapy

    Nov 1, 2015, 00:00

  • Healthcare Use and Expenditure for Diabetes In Bangladesh- A Matched-Case-Control Study

    Nov 1, 2015, 00:00

  • A Framework for Prioritizing Research Investments in Precision Medicine

    Nov 1, 2015, 00:00

  • Economic Evaluation For The Rapid Test Dpp® Hiv-Syphilis Assay With Immunochromatography In Pregnant Women In Mexico

    Nov 1, 2015, 00:00

  • Cost-Effectiveness Analysis of Pregabalin In The Treatment of Central Neuropathic Pain

    Nov 1, 2015, 00:00

  • Opportunities with Accelerated Approval Times, but Stumbles at Hta? the Impact of a Limited Evidence Package

    Nov 1, 2015, 00:00

  • Effectiveness Of The St2 For Prognosis In Heart Failure- Systematic Reviews

    Nov 1, 2015, 00:00

  • A Time and Motion Study of Denosumab Subcutaneous Injection and Zoledronic Acid Intravenous Infusion in Patients with Metastatic Bone Disease in Belgium

    Nov 1, 2015, 00:00

  • Newer Antiepileptic Drugs Dispensed By Community Pharmacies- Generic Prescribing and Cost

    Nov 1, 2015, 00:00

  • Epidemiology of Patients Affected by Acute Coronary Syndrome (Acs) Treated with Statins for Hypercholesterolemia from Italian Administrative Official Databases

    Nov 1, 2015, 00:00

  • Development Of A Web-Based Quality Of Life Portal For Breast Cancer Patients

    Nov 1, 2015, 00:00

  • Cost Analysis of Proton Pump Inhibitors In The Treatment of Gastroesophageal Reflux Disease In Ukraine

    Nov 1, 2015, 00:00

  • Health Services Utilization By Dengue Patient In Brazil, 2012 – 2013- A Multicenter Study

    Nov 1, 2015, 00:00

  • Are Vaccinations Really Different to Pharmaceuticals With Respect to Market Access In Germany?

    Nov 1, 2015, 00:00

  • Use of Quality of Care (Qoc) Metrics Among Oncologists In the United States (Us)

    Nov 1, 2015, 00:00

  • Economic Impact of Expanded Use of Biologic Therapy for Crohn’s Disease In Latin American Countries

    Nov 1, 2015, 00:00

  • Análisis Del Modelo de Toma de Decisiones Sobre Cobertura de Medicamentos en Chile

    Nov 1, 2015, 00:00

  • Economic Burden Of Acute Myocardial Infarction In Vietnam

    Nov 1, 2015, 00:00

  • A Systematic Review of Economic Evaluations in Latin America- Assessing the Factors that affect Adaptation and Transferability of Results

    Nov 1, 2015, 00:00

  • Impact of Hta – an Irish Case Study

    Nov 1, 2015, 00:00

  • A Retrospective Analysis of Time to Market Access and the Regional Impact of Spanish ‘Place in Therapy’ Reports

    Nov 1, 2015, 00:00

  • Occurrence of Treatment Interruption During Therapy with Biological Agents in Patients with Previous Anti-Tnf Failure in Rheumatoid Arthritis

    Nov 1, 2015, 00:00

  • Exploring Attitudes and Perceptions of Patients and Staff Towards a Fee For Service “After Hours” Clinic Supplementing Free Hiv Services in Uganda- A Qualitative Study

    Nov 1, 2015, 00:00

  • Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc)- A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)

    Nov 1, 2015, 00:00

  • Health-Related Quality of Life (Hrqol) In Splenectomized Immune Thrombocytopenia (Itp) Patients – A Targeted Literature Review

    Nov 1, 2015, 00:00

  • Cancer Is Associated With Intraoperative And Postprocedural Complications And Disorders

    Nov 1, 2015, 00:00

  • How Do we Estimate Quality Adjusted Life Years (Qalys) in Rare Diseases? A Case Study in Hypophosphatasia

    Nov 1, 2015, 00:00
  • «
  • 91
  • 92
  • 93
  • 94
  • 95 (current)
  • 96
  • 97
  • 98
  • 99
  • 100
  • »